VEGF receptor signaling in vertebrate development

Organogenesis

Volumn 6, Issue 2, 2010, Pages 97-106

  Vieira, Joaquim Miguel ^a,b   Ruhrberg, Christiana ^a   Schwarz, Quenten ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c CENTRE FOR CANCER BIOLOGY   (Australia)

Author keywords

FLK1; FLT1; HSPG; KDR; Neuropilin; VEGF; VEGFR1; VEGFR2

Indexed keywords

HEPARAN SULFATE; NEUROPILIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEOGLYCAN; TYROSINE KINASE RECEPTOR; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; ENZYME REGULATION; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; TISSUE CULTURE; VERTEBRATE;

VERTEBRATA;

EID: 77953496216     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.4161/org.6.2.11686     Document Type: Review

References (140)

1. Ruhrberg C. Growing and shaping the vascular tree: Multiple roles for VEGF. Bioessays 2003; 25:1052-60.
2. Praloran V. Structure, biosynthesis and biological roles of monocyte-macrophage colony stimulating factor (CSF1 or MCSF). Nouv Rev Fr Hematol 1991; 33:323-33.
3. Guerrin M, Moukadiri H, Chollet P, et al. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol 1995; 164:385-94.
4. Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999; 19:5731-40.
5. Grosskreutz CL, Anand-Apte B, Duplaa C, et al. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res 1999; 58:128-36.
6. Wang H, Keiser JA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt1. Circ Res 1998; 83:832-40.
7. Clauss M, Gerlach M, Gerlach H, et al. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte pro-coagulant activity, and promotes monocyte migration. J Exp Med 1990; 172:1535-45.
8. Senger DR, Ledbetter SR, Claffey KP, et al. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin and thrombin. Am J Pathol 1996; 149:293-305.
9. Cleaver O, Krieg PA. VEGF mediates angioblast migration during development of the dorsal aorta in Xenopus. Development 1998; 125:3905-14.
10. Shalaby F, Ho J, Stanford WL, et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 1997; 89:981-90.
11. Schwarz Q, Gu C, Fujisawa H, et al. Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve. Genes Dev 2004; 18:2822-34. (Pubitemid 39507774)
12. Silverman WF, Krum JM, Mani N, et al. Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience 1999; 90:1529-41. (Pubitemid 29170166)
13. Zelzer E, Mamluk R, Ferrara N, et al. VEGFA is necessary for chondrocyte survival during bone development. Development 2004; 131:2161-71. (Pubitemid 38702047)
14. Maes C, Stockmans I, Moermans K, et al. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J Clin Invest 2004; 113:188-99. (Pubitemid 38544204)
15. Olsson AK, Dimberg A, Kreuger J, et al. VEGF receptor signaling - In control of vascular function. Nat Rev Mol Cell Biol 2006; 7:359-71.
16. Davis-Smyth T, Presta LG, Ferrara N. Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt1 required for binding and structural stability. J Biol Chem 1998; 273:3216-22. (Pubitemid 28109731)
17. Fuh G, Li B, Crowley C, et al. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J Biol Chem 1998; 273:11197-204. (Pubitemid 28204970)
18. Shinkai A, Ito M, Anazawa H, et al. Mapping of the sites involved in ligand association and dissociation at the extracellular domain of the kinase insert domain-containing receptor for vascular endothelial growth factor. J Biol Chem 1998; 273:31283-8. (Pubitemid 28533144)
19. Cebe-Suarez S, Zehnder-Fjallman A, Ballmer-Hofer K. The role of VEGF receptors in angiogenesis; complex partnerships. Cell Mol Life Sci 2006; 63:601-15.
20. Kendall RL, Wang G, DiSalvo J, et al. Specificity of vascular endothelial cell growth factor receptor ligand binding domains. Biochem Biophys Res Commun 1994; 201:326-30. (Pubitemid 24213730)
21. Huang K, Andersson C, Roomans GM, et al. Signaling properties of VEGF receptor1 and 2 homo and heterodimers. Int J Biochem Cell Biol 2001; 33:315-24. (Pubitemid 32324000)
22. Peters KG, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993; 90:8915-9.
23. Gerber HP, Condorelli F, Park J, et al. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt1, but not Flk1/ KDR, is upregulated by hypoxia. J Biol Chem 1997; 272:23659-67.
24. Bellik L, Vinci MC, Filippi S, et al. Intracellular pathways triggered by the selective FLT1agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia. Br J Pharmacol 2005; 146:568-75.
25. Hattori K, Heissig B, Wu Y, et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone marrow microenvironment. Nat Med 2002; 8:841-9.
26. Bellamy WT. Vascular endothelial growth factor as a target opportunity in hematological malignancies. Curr Opin Oncol 2002; 14:649-56.
27. Ishida A, Murray J, Saito Y, et al. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol 2001; 188:359-68.
28. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood island formation and vasculogenesis in Flk1 deficient mice. Nature 1995; 376:62-6.
29. Ogunshola OO, Antic A, Donoghue MJ, et al. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem 2002; 277:11410-5.
30. Yang X, Cepko CL. Flk1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J Neurosci 1996; 16:6089-99. (Pubitemid 26313984)
31. Casella I, Feccia T, Chelucci C, et al. Autocrineparacrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor. Blood 2003; 101:1316-23.
32. Selheim F, Holmsen H, Vassbotn FS. Identification of functional VEGF receptors on human platelets. FEBS Lett 2002; 512:107-10.
33. Sawano A, Iwai S, Sakurai Y, et al. Flt1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 2001; 97:785-91.
34. Clauss M, Weich H, Breier G, et al. The vascular endothelial growth factor receptor Flt1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996; 271:17629-34.
35. Barleon B, Sozzani S, Zhou D, et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt1. Blood 1996; 87:3336-43.
36. Dikov MM, Ohm JE, Ray N, et al. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J Immunol 2005; 174:215-22.
37. Nomura M, Yamagishi S, Harada S, et al. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxiainduced proliferation of endothelial cells and pericytes. J Biol Chem 1995; 270:28316-24.
38. Kaipainen A, Korhonen J, Pajusola K, et al. The related FLT4, FLT1 and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med 1993; 178:2077-88. (Pubitemid 23344864)
39. Fong GH, Rossant J, Gertsenstein M, et al. Role of the Flt1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376:66-70.
40. Fong GH, Zhang L, Bryce DM, et al. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt1 knockout mice. Development 1999; 126:3015-25. (Pubitemid 29355693)
41. Waltenberger J, Claesson-Welsh L, Siegbahn A, et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994; 269:26988-95. (Pubitemid 24332901)
42. Olofsson B, Korpelainen E, Pepper MS, et al. Vascular endothelial growth factor B (VEGFB) binds to VEGF receptor1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA 1998; 95:11709-14. (Pubitemid 28460479)
43. Gille H, Kowalski J, Li B, et al. Analysis of biological effects and signaling properties of Flt1 (VEGFR1) and KDR (VEGFR2): A reassessment using novel receptorspecific vascular endothelial growth factor mutants. J Biol Chem 2001; 276:3222-30.
44. Hiratsuka S, Minowa O, Kuno J, et al. Flt1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 1998; 95:9349-54.
45. Kearney JB, Kappas NC, Ellerstrom C, et al. The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis. Blood 2004; 103:4527-35.
46. Hiratsuka S, Maru Y, Okada A, et al. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. Cancer Res 2001; 61:1207-13.
47. Autiero M, Waltenberger J, Communi D, et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003; 9:936-43.
48. Selvaraj SK, Giri RK, Perelman N, et al. Mechanism of monocyte activation and expression of pro-inflammatory cytochemokines by placenta growth factor. Blood 2003; 102:1515-24.
49. Adini A, Kornaga T, Firoozbakht F, et al. Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res 2002; 62:2749-52.
50. Park JE, Chen HH, Winer J, et al. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt1 but not to Flk1/KDR. J Biol Chem 1994; 269:25646-54.
51. Parenti A, Brogelli L, Filippi S, et al. Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGFA: Role of flt1/VEGFreceptor1. Cardiovasc Res 2002; 55:201-12.
52. Luttun A, Tjwa M, Moons L, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by antiFlt1. Nat Med 2002; 8:831-40.
53. Grunewald M, Avraham I, Dor Y, et al. VEGF-induced adult neovascularization: Recruitment, retention and role of accessory cells. Cell 2006; 124:175-89.
54. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7:1194-201.
55. Matsumoto T, Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 2001; 2001:21.
56. Gille H, Kowalski J, Yu L, et al. A repressor sequence in the juxtamembrane domain of Flt1 (VEGFR1) constitutively inhibits vascular endothelial growth factordependent phosphatidylinositol 3'kinase activation and endothelial cell migration. EMBO J 2000; 19:4064-73. (Pubitemid 30608545)
57. Chou MT, Wang J, Fujita DJ. Src kinase becomes preferentially associated with the VEGFR, KDR/Flk1, following VEGF stimulation of vascular endothelial cells. BMC Biochem 2002; 3:32.
58. Stein PL, Vogel H, Soriano P. Combined deficiencies of Src, Fyn and Yes tyrosine kinases in mutant mice. Genes Dev 1994; 8:1999-2007.
59. Ito N, Huang K, ClaessonWelsh L. Signal transduction by VEGF receptor1 wild type and mutant proteins. Cell Signal 2001; 13:849-54. (Pubitemid 32913694)
60. Terman BI, Dougher-Vermazen M, Carrion ME, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992; 187:1579-86.
61. Quinn TP, Peters KG, De Vries C, et al. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 1993; 90:7533-7.
62. Bernatchez PN, Soker S, Sirois MG. Vascular endothelial growth factor effect on endothelial cell proliferation, migration and platelet-activating factor synthesis is Flk1dependent. J Biol Chem 1999; 274:31047-54.
63. Takahashi T, Yamaguchi S, Chida K, et al. A single autophosphorylation site on KDR/Flk1 is essential for VEGFA-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 2001; 20:2768-78.
64. Werdich XQ, Penn JS. Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events. Angiogenesis 2005; 8:315-26.
65. Eliceiri BP, Paul R, Schwartzberg PL, et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 1999; 4:915-24.
66. Rajagopal K, Sommers CL, Decker DC, et al. RIBP, a novel Rlk/Txk and itk-binding adaptor protein that regulates T cell activation. J Exp Med 1999; 190:1657-68.
67. Lamalice L, Houle F, Jourdan G, et al. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. Oncogene 2004; 23:434-45. (Pubitemid 38174998)
68. Holmqvist K, Cross MJ, Rolny C, et al. The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor2 and regulates VEGF-dependent cellular migration. J Biol Chem 2004; 279:22267-75.
69. Sakurai Y, Ohgimoto K, Kataoka Y, et al. Essential role of Flk1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc Natl Acad Sci USA 2005; 102:1076-81. (Pubitemid 40170728)
70. Aouadi M, Binetruy B, Caron L, et al. Role of MAPKs in development and differentiation: Lessons from knockout mice. Biochimie 2006; 88:1091-8.
71. Lai KM, Pawson T. The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. Genes Dev 2000; 14:1132-45.
72. Sakai R, Henderson JT, O'Bryan JP, et al. The mammalian ShcB and ShcC phosphotyrosine docking proteins function in the maturation of sensory and sympathetic neurons. Neuron 2000; 28:819-33. (Pubitemid 32038074)
73. Kriz V, Agren N, Lindholm CK, et al. The SHB adapter protein is required for normal maturation of mesoderm during in vitro differentiation of embryonic stem cells. J Biol Chem 2006; 281:34484-91.
74. Haigh JJ, Morelli PI, Gerhardt H, et al. Cortical and retinal defects caused by dosage-dependent reductions in VEGFA paracrine signaling. Dev Biol 2003; 262:225-41.
75. Lee S, Chen TT, Barber CL, et al. Autocrine VEGF signaling is required for vascular homeostasis. Cell 2007; 130:691-703.
76. Serini G, Valdembri D, Bussolino F. Integrins and angiogenesis: A sticky business. Exp Cell Res 2006; 312:651-8.
77. Carmeliet P, Collen D. Molecular basis of angiogenesis: Role of VEGF and VE-cadherin. Ann NY Acad Sci 2000; 902:249-62.
78. Carmeliet P, Lampugnani MG, Moons L, et al. Targeted deficiency or cytosolic truncation of the VEcadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 1999; 98:147-57. (Pubitemid 29344903)
79. Sun JF, Phung T, Shiojima I, et al. Microvascular patterning is controlled by fine-tuning the Akt signal. Proc Natl Acad Sci USA 2005; 102:128-33.
80. Gerber HP, McMurtrey A, Kowalski J, et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'kinase/Akt signal transduction pathway. Requirement for Flk1/ KDR activation. J Biol Chem 1998; 273:30336-43.
81. Thakker GD, Hajjar DP, Muller WA, et al. The role of phosphatidylinositol 3kinase in vascular endothelial growth factor signaling. J Biol Chem 1999; 274:10002-7.
82. Lampugnani MG, Orsenigo F, Gagliani MC, et al. Vascular endothelial cadherin controls VEGFR2 internalization and signaling from intracellular compartments. J Cell Biol 2006; 174:593-604.
83. Guo DQ, Wu LW, Dunbar JD, et al. Tumor necrosis factor employs a proteintyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 2000; 275:11216-21.
84. Gallicchio M, Mitola S, Valdembri D, et al. Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor. Blood 2005; 105:1970-6.
85. Huang L, Sankar S, Lin C, et al. HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity. J Biol Chem 1999; 274:38183-8.
86. Gitay-Goren H, Cohen T, Tessler S, et al. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem 1996; 271:5519-23.
87. Soker S, Fidder H, Neufeld G, et al. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7encoded domain. J Biol Chem 1996; 271:5761-7.
88. Takagi S, Tsuji T, Amagai T, et al. Specific cell surface labels in the visual centers of Xenopus laevis tadpole identified using monoclonal antibodies. Dev Biol 1987; 122:90-100.
89. Fujisawa H, Ohtsuki T, Takagi S, et al. An aberrant retinal pathway and visual centers in Xenopus tadpoles share a common cell surface molecule, A5 antigen. Dev Biol 1989; 135:231-40.
90. He Z, Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 1997; 90:739-51.
91. Kolodkin AL, Levengood DV, Rowe EG, et al. Neuropilin is a semaphorin III receptor. Cell 1997; 90:753-62.
92. Chen H, Chedotal A, He Z, et al. Neuropilin2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 1997; 19:547-59.
93. Gluzman-Poltorak Z, Cohen T, Herzog Y, et al. Neuropilin2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF145 and VEGF165 [corrected]. J Biol Chem 2000; 275:18040-5.
94. Takagi S, Hirata T, Agata K, et al. The A5 antigen, a candidate for the neuronal recognition molecule, has homologies to complement components and coagulation factors. Neuron 1991; 7:295-307.
95. Lee CC, Kreusch A, McMullan D, et al. Crystal structure of the human neuropilin1 b1 domain. Structure 2003; 11:99-108.
96. Nakamura F, Tanaka M, Takahashi T, et al. Neuropilin1 extracellular domains mediate semaphorin D/III-induced growth cone collapse. Neuron 1998; 21:1093-100.
97. Rohm B, Ottemeyer A, Lohrum M, et al. Plexin/ neuropilin complexes mediate repulsion by the axonal guidance signal semaphorin 3A. Mech Dev 2000; 93:95-104.
98. Tamagnone L, Artigiani S, Chen H, et al. Plexins are a large family of receptors for transmembrane, secreted and GPI-anchored semaphorins in vertebrates. Cell 1999; 99:71-80.
99. Soker S, Takashima S, Miao HQ, et al. Neuropilin1 is expressed by endothelial and tumor cells as an isoformspecific receptor for vascular endothelial growth factor. Cell 1998; 92:735-45.
100. Kitsukawa T, Shimizu M, Sanbo M, et al. Neuropilinsemaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron 1997; 19:995-1005.
101. Kawasaki T, Bekku Y, Suto F, et al. Requirement of neuropilin 1mediated Sema3A signals in patterning of the sympathetic nervous system. Development 2002; 129:671-80.
102. Marin O, Yaron A, Bagri A, et al. Sorting of striatal and cortical interneurons regulated by semaphorinneuropilin interactions. Science 2001; 293:872-5.
103. Giger RJ, Cloutier JF, Sahay A, et al. Neuropilin2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron 2000; 25:29-41. (Pubitemid 30316508)
104. Chen H, Bagri A, Zupicich JA, et al. Neuropilin2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections. Neuron 2000; 25:43-56. (Pubitemid 30316509)
105. Herzog Y, Kalcheim C, Kahane N, et al. Differential expression of neuropilin1 and neuropilin2 in arteries and veins. Mech Dev 2001; 109:115-9. (Pubitemid 33035924)
106. Kitsukawa T, Shimono A, Kawakami A, et al. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 1995; 121:4309-18. (Pubitemid 26007578)
107. Kawasaki T, Kitsukawa T, Bekku Y, et al. A requirement for neuropilin1 in embryonic vessel formation. Development 1999; 126:4895-902.
108. Lee P, Goishi K, Davidson AJ, et al. Neuropilin1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proc Natl Acad Sci USA 2002; 99:10470-5.
109. Wang L, Mukhopadhyay D, Xu X. C terminus of RGS-GAIP-interacting protein conveys neuropilin1- mediated signaling during angiogenesis. FASEB J 2006; 20:1513-5.
110. Yuan L, Moyon D, Pardanaud L, et al. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 2002; 129:4797-806.
111. Takashima S, Kitakaze M, Asakura M, et al. Targeting of both mouse neuropilin1 and neuropilin2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci USA 2002; 99:3657-62.
112. Favier B, Alam A, Barron P, et al. Neuropilin2 interacts with VEGFR2 and VEGFR3 and promotes human endothelial cell survival and migration. Blood 2006; 108:1243-50.
113. Gu C, Rodriguez ER, Reimert DV, et al. Neuropilin1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell 2003; 5:45-57.
114. Ruhrberg C, Gerhardt H, Golding M, et al. Spatially restricted patterning cues provided by heparin-binding VEGFA control blood vessel branching morphogenesis. Genes Dev 2002; 16:2684-98.
115. Gerhardt H, Ruhrberg C, Abramsson A, et al. Neuropilin1 is required for endothelial tip cell guidance in the developing central nervous system. Dev Dyn 2004; 231:503-9.
116. Miao HQ, Soker S, Feiner L, et al. Neuropilin1 mediates collapsin1/semaphorin III inhibition of endothelial cell motility: Functional competition of collapsin1 and vascular endothelial growth factor165. J Cell Biol 1999; 146:233-42.
117. Vieira JM, Schwarz Q, Ruhrberg C. Selective requirements for NRP1 ligands during neurovascular patterning. Development 2007; 134:1833-43.
118. Fuh G, Garcia KC, de Vos AM. The interaction of neuropilin1 with vascular endothelial growth factor and its receptor flt1. J Biol Chem 2000; 275:26690-5.
119. Whitaker GB, Limberg BJ, Rosenbaum JS. Vascular endothelial growth factor receptor2 and neuropilin1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). J Biol Chem 2001; 276:25520-31.
120. Soker S, Miao HQ, Nomi M, et al. VEGF165 mediates formation of complexes containing VEGFR2 and neuropilin1 that enhance VEGF165 receptor binding. J Cell Biochem 2002; 85:357-68.
121. Wang L, Zeng H, Wang P, et al. Neuropilin1mediated vascular permeability factor/vascular endothelial growth factordependent endothelial cell migration. J Biol Chem 2003; 278:48848-60.
122. Cai H, Reed RR. Cloning and characterization of neuropilin1interacting protein: A PSD95/Dlg/ZO1 domaincontaining protein that interacts with the cytoplasmic domain of neuropilin1. J Neurosci 1999; 19:6519-27.
123. Chittenden TW, Claes F, Lanahan AA, et al. Selective regulation of arterial branching morphogenesis by synectin. Dev Cell 2006; 10:783-95.
124. Mukouyama YS, Gerber HP, Ferrara N, et al. Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1mediated positive feedback. Development 2005; 132:941-52.
125. Stalmans I, Ng YS, Rohan R, et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 2002; 109:327-36.
126. Bernfield M, Kokenyesi R, Kato M, et al. Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 1992; 8:365-93.
127. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993; 4:1317-26.
128. Gerhardt H, Golding M, Fruttiger M, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161:1163-77.
129. Tessler S, Rockwell P, Hicklin D, et al. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk1 receptors. J Biol Chem 1994; 269:12456-61.
130. Terman B, Khandke L, Dougher-Vermazan M, et al. VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors 1994; 11:187-95.
131. AshikariHada S, Habuchi H, Kariya Y, et al. Heparin regulates vascular endothelial growth factor165 dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells: Comparison of the effects of heparin and modified heparins. J Biol Chem 2005; 280:31508-15.
132. Jakobsson L, Kreuger J, Holmborn K, et al. Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev Cell 2006; 10:625-34.
133. Shintani Y, Takashima S, Asano Y, et al. Glycosaminoglycan modification of neuropilin1 modulates VEGFR2 signaling. EMBO J 2006; 25:3045-55.
134. Dougher M, Terman BI. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization. Oncogene 1999; 18:1619-27.
135. Feng Y, Venema VJ, Venema RC, et al. VEGF induces nuclear translocation of Flk1/KDR, endothelial nitric oxide synthase, and caveolin1 in vascular endothelial cells. Biochem Biophys Res Commun 1999; 256:192-7.
136. Li W, Keller G. VEGF nuclear accumulation correlates with phenotypical changes in endothelial cells. J Cell Sci 2000; 113:1525-34.
137. Ilan N, Tucker A, Madri JA. Vascular endothelial growth factor expression, beta-catenin tyrosine phosphorylation, and endothelial proliferative behavior: A pathway for transformation? Lab Invest 2003; 83:1105-15.
138. Santos SC, Miguel C, Domingues I, et al. VEGF and VEGFR2 (KDR) internalization is required for endothelial recovery during wound healing. Exp Cell Res 2007; 313:1561-74.
139. Pan Q, Chanthery Y, Liang WC, et al. Blocking neuropilin1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 2007; 11:53-67.
140. Hamada K, Sasaki T, Koni PA, et al. The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev 2005; 19:2054-65.